Keith Tode, MBA

Executive Vice President, Decentralized Clinical Trials at AMC Health

Overview

Keith Tode holds the position of Executive Vice President, Decentralized Clinical Trials at AMC Health [1][3]. Tode has served as Chief Commercial Officer twice and held multiple Vice President roles, including Global Head of International Operations [2]. Tode's career includes founding KRT Global Advisory, LLC in July 2023 [4], serving as Chief Commercial Officer at Cardiovascular Clinical Sciences from December 2022 to July 2023 [5], and holding the position of VP, Clinical Trials and Head of International Operations at Net Health from January to October 2022 [6]. Earlier roles included VP, Clinical Solutions and Rare Disease Patient Recruitment at IPM.ai [7], Chief Growth Officer at 2M Clinical Inc [8], and Senior Director, Strategic Partnerships at MCRA [10]. Tode holds an MBA in Finance from Norwich University and a BA in Political Science from the University of New Hampshire [11][12].

Profile introduction
Source excerptLinkedIn [2]

Two-Time Chief Commercial Officer with global experience across pharmaceuticals, biotechnology, medical device, HealthTech, CROs and FSPs. He has generated over $500m+ in revenue, managed P&Ls more than $75m+, delivered years of 200%+ growth and commercialized FDA Breakthrough AI/ML technologies. Builds, restructures and manages multinational teams, drives strategic partnerships, and integrates innovation into clinical, regulatory, quality and commercial operations. Summary of Qualifications • Executive Leadership: Two-time CCO with multiple VP roles and Global Head of International Oper…

Career history

  1. Executive Vice President, Decentralized Clinical TrialsDec 2025 to presentAMC Health
  2. Founder & CEOJul 2023 to presentKRT Global Advisory, LLC
  3. Chief Commercial Officer (Corporate Restructure)Dec 2022 to Jul 2023Cardiovascular Clinical Sciences
  4. VP, Clinical Trials & Head of International Operations (Corporate Restructure)Jan 2022 to Oct 2022Net Health
  5. VP, Clinical Solutions & Rare Disease Patient Recruitment (Corporate Restructure)2021 to 2021IPM.ai (Acquired by Real Chemistry)
  6. Chief Growth Officer2020 to 20212M Clinical Inc
  7. Founder & CEOJul 2018 to Apr 2020Northfield Global Consulting, LLC
  8. Senior Director, Strategic PartnershipsApr 2017 to Jun 2018Musculoskeletal Clinical Regulatory Advisers, LLC (MCRA)

Education

  1. BA, Political ScienceUniversity of New Hampshire
  2. MBA, FinanceNorwich University

This page shows public professional information only, each fact cited. Is this you? send a correction, or ask for removal within 24 hours, no questions asked.